PBA
Paradigm Biocapital Advisors’s Arcellx ACLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306M | Buy |
4,649,016
+156,984
| +3% | +$10.3M | 13.07% | 2 |
|
|
2025
Q1 | $295M | Buy |
4,492,032
+120,431
| +3% | +$7.9M | 13.5% | 2 |
|
|
2024
Q4 | $335M | Buy |
4,371,601
+371,601
| +9% | +$28.5M | 11.66% | 2 |
|
|
2024
Q3 | $334M | Buy |
4,000,000
+151,905
| +4% | +$12.7M | 11.3% | 2 |
|
|
2024
Q2 | $212M | Buy |
3,848,095
+30,000
| +0.8% | +$1.66M | 8.13% | 3 |
|
|
2024
Q1 | $266M | Buy |
3,818,095
+159,471
| +4% | +$11.1M | 9.35% | 2 |
|
|
2023
Q4 | $203M | Buy |
3,658,624
+705,502
| +24% | +$39.2M | 9.51% | 2 |
|
|
2023
Q3 | $106M | Buy |
2,953,122
+606,122
| +26% | +$21.7M | 7.19% | 3 |
|
|
2023
Q2 | $74.2M | Buy |
2,347,000
+589,221
| +34% | +$18.6M | 5.73% | 4 |
|
|
2023
Q1 | $54.2M | Buy |
1,757,779
+875,678
| +99% | +$27M | 5.13% | 7 |
|
|
2022
Q4 | $27.3M | Buy |
+882,101
| New | +$27.3M | 3.21% | 16 |
|